Tocilizumab: from the rheumatology practice to the fight against COVID-19, a virus infection with multiple faces
Miguel Á. González‐Gay, José Mayo, Santos Castañeda, José M. Cifrián, José Hernández‐Rodríguez
Abstract
KEYWORDS: Chimeric antigen receptor (CAR) T cell‐induced cytokine release syndromecoronavirusCOVID-19inflammationinterleukin-6macrophage activation syndrometocilizumabanakinracolchicine
Topics & Concepts
TocilizumabCoronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)RheumatologyCytokine release syndromeChimeric antigen receptor2019-20 coronavirus outbreakImmunologyVirologyVirusReceptorAntigenInternal medicineT cellImmune systemRheumatoid arthritisDiseaseInfectious disease (medical specialty)OutbreakCAR-T cell therapy researchAutoimmune and Inflammatory Disorders ResearchViral Infections and Immunology Research